Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Metixene hydrochloride hydrate has potential anticholinergic activity and inhibits the binding of quinine ring benzoate (QNB) to muscarine receptors, with IC50 and Ki values of 55 nM and 15 nM, respectively. Metixene hydrochloride hydrate can be used to prevent and treat Parkinson's disease.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 35.00 | |
10 mg | In stock | $ 55.00 | |
25 mg | In stock | $ 113.00 | |
50 mg | In stock | $ 178.00 | |
100 mg | In stock | $ 289.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 61.00 |
Description | Metixene hydrochloride hydrate has potential anticholinergic activity and inhibits the binding of quinine ring benzoate (QNB) to muscarine receptors, with IC50 and Ki values of 55 nM and 15 nM, respectively. Metixene hydrochloride hydrate can be used to prevent and treat Parkinson's disease. |
Targets&IC50 | mAChR:55 nM, mAChR:15 nM (Ki) |
In vitro | Metixene hydrochloride hydrate, with IC50 and Ki values of 55 nM and 15 nM, respectively, has the potential to inhibit the binding of QNB with the muscarinic receptor [1]. |
Molecular Weight | 363.95 |
Formula | C20H26ClNOS |
CAS No. | 7081-40-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 5 mg/mL (13.74c), Sonification is recommended.
DMSO: 70 mg/mL (192.34 mM), Sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Metixene hydrochloride hydrate 7081-40-5 Neuroscience AChR Metixene hydrochloride Hydrate inhibitor inhibit